BDTX icon

Black Diamond Therapeutics

73 hedge funds and large institutions have $107M invested in Black Diamond Therapeutics in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
-1
Holders Change %
-1.35%
% of All Funds
1.16%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
17
Increased
23
Reduced
15
Closed
17
Calls
$1.05M
Puts
$109K
Net Calls
+$944K
Net Calls Change
-$1.77M
Name Holding Trade Value Shares
Change
Shares
Change %
SCM
76
Soleus Capital Management
Connecticut
-$2.2M -435,000 Closed
VA
77
VR Adviser
New York
-$1.79M -353,629 Closed
OM
78
Opaleye Management
Massachusetts
-$1.39M -275,000 Closed
MS
79
Maven Securities
Jersey
-$947K -187,513 Closed
MIM
80
Monashee Investment Management
Massachusetts
-$859K -170,000 Closed
E
81
Ergoteles
New York
-$505K -100,000 Closed
Acadian Asset Management
82
Acadian Asset Management
Massachusetts
-$268K -53,365 Closed
HSBC Holdings
83
HSBC Holdings
United Kingdom
-$120K -24,156 Closed
CSS
84
Cubist Systematic Strategies
Connecticut
-$117K -23,210 Closed
Bank of Montreal
85
Bank of Montreal
Ontario, Canada
-$76.4K -15,000 Closed
State of Wisconsin Investment Board
86
State of Wisconsin Investment Board
Wisconsin
-$61.1K -12,100 Closed
Royal Bank of Canada
87
Royal Bank of Canada
Ontario, Canada
-$7K -1,355 Closed
Simplex Trading
88
Simplex Trading
Illinois
-$1K -350 Closed
SIC
89
Salem Investment Counselors
North Carolina
-$177 -35 Closed